Home › Thyroid Cancer › NCT02747888
Hereditary Risk Factors for Thyroid Cancer
Who can join
All ages · All sexes · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria:
* Individual pediatric patient with current or previous known or suspected thyroid cancer or nodule(s).
* Individual adult patient with current or previous known or suspected thyroid cancer or nodule(s) if they come from a family with a high suspicion of hereditary cancer (as below).
* Individuals from families with a high suspicion of hereditary thyroid cancer:
* Families with a current or previous diagnosis of a thyroid cancer/nodule occurring in childhood (\<18 years old).
* Families with a high suspicion of hereditary thyroid cancer/nodules other than above to include:
* Families with thyroid cancer in multiple individuals
* Families with thyroid cancer and a known genetic syndrome
* Families with thyroid cancer and a suspected genetic syndrome (e.g. multiple childhood cancers in the family, multiple primary cancers, multiple endocrinopathies, etc.)
Exclusion Criteria:
* Individuals who are unable to give informed consent.
* Individuals who are unable to complete study materials.About the study
Thyroid cancers can occur sporadically, but can also be found as tumors that cluster in families with other cancers or genetic syndromes. Researchers are studying thyroid cancer in children and families, with a particular interest in understanding genes and other factors that may put individuals at risk for developing thyroid cancer and thyroid nodules.
* In this study, family and medical history information is collected alongside a blood or saliva sample for genetic studies. * Individuals with a past or present childhood thyroid cancer/nodule or a thyroid cancer suspected to be inherited in their family are invited to participate.
What is being tested
- •Referral to Genetic Counselor, if indicated (genetic)
Sponsor: Dana-Farber Cancer Institute · Participants: 250 · Started: Mar 1, 2016
Contact the study team
- Junne Kamihara, MD, PhD · Phone: 617.632.3044
Official record on ClinicalTrials.gov — NCT02747888
Locations in the U.S.
| Massachusetts | Dana Farber Cancer Institute, Boston |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.